InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2021-12-13 00:00:00 ET · period of report 2021-12-10 · accession 0001104659-21-149242 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-13 2021-12-10 AMPH PRINS RICHARD K Dir M - OptEx $17.11 +5,291 50.5K +12% +$90.5K
D 2021-12-13 2021-12-10 AMPH PRINS RICHARD K Dir S - Sale+OE $21.36 -5,291 45.2K -10% -$113.0K
D 2021-12-13 2021-12-10 AMPH PRINS RICHARD K Dir M - OptEx $0.00 -5,291 10.0K -35% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-10 M A 5,291 $17.11 50,470 D — —
2 Common Common Stock 2021-12-10 S D 5,291 $21.36 45,179 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.35 to $21.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (right to buy) 2021-12-10 M D 5,291 $0.00 10,000 D $17.11 · — to 2022-06-08 5,291 Common Stock (F2) Shares subject to the option are fully vested and immediately exercisable.